Clinical Trials Logo

Clinical Trial Summary

The primary purpose of your participation in this study is to help answer the following research question, and not to provide you treatment for your condition.

Whether duloxetine once daily can help patients with Chronic Low Back Pain.

Patients who do not have their pain reduced by at least 30% by week 7 will be given 120 mg dose for the duration of the study. After the 13 week double blind period, patients randomized to placebo will switch to duloxetine 60 mg or 120 mg in the 41-week extension period.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00424593
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 3
Start date January 2007
Completion date October 2008

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03106740 - Evaluating the Role of Neuroinflammation in Low Back Pain Phase 2
Withdrawn NCT03449160 - Postural Training Device (UPRIGHT) for Back Pain N/A
Completed NCT03984903 - Different Learning Methods of Motor Control Exercises N/A
Completed NCT03861611 - A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain. Phase 4
Completed NCT04968535 - Effect of Regular Electrotherapy in Patients With Chronic Non-specific Neck Pain and Low-back Pain N/A
Completed NCT05585294 - Water Versus Land Based Perturbation Exercises in Elderly Participants With Back Pain N/A
Completed NCT00408876 - Duloxetine Versus Placebo in Chronic Low Back Pain Phase 3
Recruiting NCT03912519 - Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy N/A